Arcadia Biosciences, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
2.18M
on 2026-06-30, from 1.36M on 2024-03-31 10-Q ↗
a raise that quarter, at its price
Newest
None
No S-3 or F-3 shelf on file in the last 30 months.
5 of its filings are not read yet.
Cash
6.6 quarters
$4.2M on 2026-06-30 ÷ $634K a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-06-11 | Private placement incl. 3.88M pre-funded | 7,766,992 | not read | $4.0M | 8-K ↗ |